Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review

August 2021 | 56 pages | ID: A46A3AA0FB1EN
GlobalData

Abstracts

Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aurobindo Pharma Ltd (Aurobindo) is a vertically integrated pharmaceutical company that manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs). Its product portfolio is spread across major therapeutic and product categories including antibiotics, anti-retroviral, systemic gastroenterological, central nervous system, cardiovascular, anti-allergies, anti-diabetics, other therapeutic areas. The company also produces novel proprietary biocatalysts, dietary supplements and fermentation based semi synthetic products. Aurobindo operates manufacturing facilities in India, Brazil, Portugal and the US; and R&D facilities in India and the US. The company exports products to several countries worldwide. Aurobindo is headquartered in Hyderabad, Telangana, India.

Aurobindo Pharma Ltd Key Recent Developments

Mar 31,2021: Aurobindo Pharma announces appointment of Mr.M.Sitarama Murty
Feb 23,2021: Agreement to acquire 26% ownerships in two solar power generating companies
Dec 29,2020: COVAXX, Aurobindo sign Covid-19 vaccine development deal
Nov 12,2020: Aurobindo Pharma ready to manufacture COVID-19 vaccines for others
Nov 05,2020: Aurobindo Pharma announces appointment of an independent director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Aurobindo Pharma Ltd - Key Facts
Aurobindo Pharma Ltd - Key Employees
Aurobindo Pharma Ltd - Major Products and Services
Aurobindo Pharma Ltd - History
Aurobindo Pharma Ltd - Company Statement
Aurobindo Pharma Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Aurobindo Pharma Ltd - Business Description
Business Segment: API Segment
Overview
Performance
Key Stats
Business Segment: ARV Formulations
Overview
Performance
Key Stats
Business Segment: EU Formulations
Overview
Performance
Business Segment: Growth Markets Formulations
Overview
Performance
Business Segment: US Formulations
Overview
Performance
Key Stats
Geographical Segment: Europe
Performance
Geographical Segment: India
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: USA
Performance
R&D Overview
Aurobindo Pharma Ltd - Corporate Strategy
Aurobindo Pharma Ltd - SWOT Analysis
SWOT Analysis - Overview
Aurobindo Pharma Ltd - Strengths
Aurobindo Pharma Ltd - Weaknesses
Aurobindo Pharma Ltd - Opportunities
Aurobindo Pharma Ltd - Threats
Aurobindo Pharma Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Aurobindo Pharma Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 31, 2021: Aurobindo Pharma announces appointment of Mr.M.Sitarama Murty
Dec 29, 2020: COVAXX, Aurobindo sign Covid-19 vaccine development deal
Nov 05, 2020: Aurobindo Pharma announces appointment of an independent director
Oct 27, 2020: Aurobindo Pharma to sell US subsidiary to New Mountain Capital affiliate
Oct 22, 2020: Aurobindo Pharma: Warning letter from USFDA
Jun 22, 2020: Aurobindo Pharma plans to launch 50-60 products in US in FY21
Jun 04, 2020: Aurobindo Pharma rises after Q4 PAT jumps 45% to Rs 850 cr
Feb 26, 2020: Aurobindo Pharma: Update on US FDA inspection at Unit VIII
Feb 21, 2020: Aurobindo Pharma: Further update on US FDA inspection at Unit IV
Feb 19, 2020: AUROBINDO PHARMA: Update on US FDA Inspection at our Unit IV

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Aurobindo Pharma Ltd, Key Facts
Aurobindo Pharma Ltd, Key Employees
Aurobindo Pharma Ltd, Major Products and Services
Aurobindo Pharma Ltd, History
Aurobindo Pharma Ltd, Other Locations
Aurobindo Pharma Ltd, Subsidiaries
Aurobindo Pharma Ltd, Joint Venture
Aurobindo Pharma Ltd, Key Competitors
Aurobindo Pharma Ltd, Ratios based on current share price
Aurobindo Pharma Ltd, Annual Ratios
Aurobindo Pharma Ltd, Annual Ratios (Cont...1)
Aurobindo Pharma Ltd, Annual Ratios (Cont...2)
Aurobindo Pharma Ltd, Interim Ratios
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Aurobindo Pharma Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Aurobindo Pharma Ltd, Performance Chart (2017 - 2021)
Aurobindo Pharma Ltd, Ratio Charts
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021